MYRIAD GENETICS INC. - COMMON STOCK

Myriad Genetics Advances International Reorganization and Completes Sale of EndoPredict Business to Eurobio Scientific

01 8 2024 15:05:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Appoints Jennifer Fox as Chief Legal Officer

31 7 2024 07:50:00 提供 Nasdaq GlobeNewswire

Myriad Genetics to Release Second Quarter 2024 Financial Results on August 6, 2024

30 7 2024 07:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

24 7 2024 09:17:07 提供 NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

23 7 2024 09:02:36 提供 NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

22 7 2024 12:44:46 提供 NetDania Notify

What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk

17 7 2024 07:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

16 7 2024 08:46:09 提供 NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

15 7 2024 08:45:02 提供 NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

12 7 2024 09:20:55 提供 NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

11 7 2024 12:01:36 提供 NetDania Notify

Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing

11 7 2024 08:00:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

09 7 2024 08:00:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Earns 2024 Great Place To Work® Certification™

02 7 2024 08:00:00 提供 Nasdaq GlobeNewswire

Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election

24 6 2024 15:05:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries

11 6 2024 07:00:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen

04 6 2024 08:00:00 提供 Nasdaq GlobeNewswire

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

03 6 2024 15:05:00 提供 Nasdaq GlobeNewswire

QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications

30 5 2024 16:55:30 提供 Nasdaq GlobeNewswire

Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting

23 5 2024 17:00:00 提供 Nasdaq GlobeNewswire